Invasive Tracheobronchial Aspergillosis in an Immunocompetent Person

Soubani, 2002, The clinical spectrum of pulmonary aspergillosis, Chest, 121, 1988, 10.1378/chest.121.6.1988 Ko, 2002, Pulmonary aspergillosis in an immunocompetent patient, J Thorac Imaging, 17, 70, 10.1097/00005382-200201000-00009 British Tuberculosis Association, 1970, Aspergilloma and residual tuberculous cavities: the results of a resurvey, Tubercle, 51, 227, 10.1016/0041-3879(70)90015-2 Karam, 1986, Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts, Rev Infect Dis, 8, 357, 10.1093/clinids/8.3.357 Lortholary, 1993, Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS, Am J Med, 95, 177, 10.1016/0002-9343(93)90258-Q Kuhlman, 1988, CT of invasive pulmonary aspergillosis, AJR Am J Roentgenol, 150, 1015, 10.2214/ajr.150.5.1015 Curtis, 1979, Air crescent sign of invasive aspergillosis, Radiology, 133, 17, 10.1148/133.1.17 Kahn, 1986, The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis, Am J Clin Pathol, 86, 518, 10.1093/ajcp/86.4.518 Denning, 1996, Therapeutic outcome in invasive aspergillosis, Clin Infect Dis, 23, 608, 10.1093/clinids/23.3.608 Caillot, 2003, Intravenous itraconazole followed by oral itraconazole for the treatment of amphotericin-B-refractory invasive pulmonary aspergillosis, Acta Haematol, 109, 111, 10.1159/000069281 Steinbach, 2003, Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001, Clin Infect Dis, 37, S188, 10.1086/376524 Johnson, 2003, Caspofungin: first approved agent in a new class of antifungals, Expert Opin Pharmacother, 4, 807, 10.1517/14656566.4.5.807